meds for buy
 
top2-3
Contact Us contactus Ελληνικά flag
top3-3
THE SOCIETY
NATIONAL CONGRESS
WORKING GROUPS SEMINARS
REGIONAL CONGRESSES OF THE HELLENIC CARDIOLOGICAL SOCIETY
SCIENTIFIC PROGRAMS
WORKING GROUPS-OLD STRUCTURE
WORKING GROUPS-NEW STRUCTURE
EDUCATION
HELLENIC JOURNAL OF CARDIOLOGY
CALENDAR
LINKS
INTERNATIONAL JOURNALS
PATIENT NEWS
WEBINARS
GUIDELINES
YOUNG CARDIOLOGISTS
ACTIONS OF THE HELLENIC CARDIOLOGICAL SOCIETY
NEWS FROM ESC
STUDIES
REGISTRIES
 
Clinical Issues
REVIEWS
Prevention
Imaging
Arterial Hypertention
Valvular Heart Disease
Thromboembolism Disease
Αrrhythmias
Coronary Artery Disease
Cardiomyopathies
Heart Failure
Echocardiography
more>>
INTERVIEWS
Atrial Fibrillation
Myocardial Infarction. How much are we at risk?
more>>
 
ESC Guidelines
COMPENDIUM of Abridged ESC Guidelines 2010
European Resuscitation Council Guidelines for Resuscitation 2010 Section 1. Executive summary
Prevention of Cardiovascular Disease
Hypertension
more>>
Special Links
 
Special Releases
NEW PUBLICATIONS
more>>
 
challenge
Herodotos
Scientific Highlights
FDA approves alirocumab, first injectable lipid-lowering
The Food and Drug Administration has approved the PCSK9 inhibitor alirocumab as a treatment for hypercholesterolemia, making this the first...
FDA approves new treatment for HF
The FDA has approved a first-in-class angiotensin receptor-neprilysin inhibitor for the reduction of CV death and HF-related hospitalization...
FDA strengthens warning of link between NSAIDs and MI, stroke
The FDA is strengthening a label warning of increased risk for MI or stroke associated with the use of nonsteroidal anti-inflammatory drugs,...
FDA warns of serious adverse events with LAA closure via suture delivery device
The FDA has issued a safety announcement warning of deaths and other serious adverse events associated with left atrial appendage closure via...
Idarucizumab: Clotting normalized in most patients with serious bleeding or needing surgery
Idarucizumab restored clotting in most patients on the new oral anticoagulant (NOAC) dabigatran (Pradaxa) who had serious bleeding or required...
FDA panel recommends approval of evolocumab
The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee voted to recommend approval of evolocumab for reduction of LDL. The...
FDA advisory committee votes to recommend approval for alirocumab
The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee today voted 13-3 that the benefits of LDL lowering via alirocumab, a human...
IMPROVE-IT published: Adding ezetimibe to simvastatin lowers LDL, improves CV outcomes
Confirming findings previously presented, adding ezetimibe to statin therapy lowered LDL levels and improved CV outcomes in patients with ACS,...
FDA grants priority review status for idarucizumab
Boehringer Ingelheim Pharmaceuticals Inc. announced that the FDA has granted priority review status for the company’s biologics license...
FDA accepts priority review application for ticagrelor for patients with prior MI
AstraZeneca announced that the FDA has accepted a supplemental new drug application and granted 6-month priority review for ticagrelor 60 mg...
FDA approves ivabradine for treatment of HF
The FDA has approved ivabradine to reduce hospitalization from worsening HF. Ivabradine (Corlanor, Amgen) is indicated for stable patients...
AHA issues recommendations for older adults with congenital heart disease
The increasing population and improved longevity of adults with congenital heart disease prompted the American Heart Association to release a...
FDA approves ivabradine for treatment of HF
The FDA has approved ivabradine to reduce hospitalization from worsening HF. Ivabradine (Corlanor, Amgen) is indicated for stable patients...
FDA finally gives a thumbs-up for cangrelor
After close to a decade of late-stage studies and stinging setbacks, The Medicines Co. may finally be on the verge of seeing its...
New administration option for ticagrelor now approved
For patients with ACS who are unable to swallow whole tablets, ticagrelor is now approved by the FDA to be crushed and administered in water by...
FDA: Use of TAVR system expanded to include aortic valve-in-valve replacement
The FDA has expanded the approved use of the CoreValve system to include aortic valve-in-valve replacement, according to an agency press...
FDA approves expansion of clinical trial for left ventricular assist system
Thoratec Corporation announced that it has received approval from the FDA to expand enrollment of the HeartMate III U.S. Clinical trial of a...
Medtronic’s CoreValve Bests Surgery at Two-Year Mark
Medtronic said recently that data from a U.S. pivotal trial showed patients who underwent transcatheter aortic valve replacement using...
FDA approves blood pump system for patients undergoing high-risk PCI
The FDA announced that it has approved a miniature blood pump system to help patients undergoing certain high-risk PCI procedures maintain...
Boston Sci's stroke-fighting Watchman overcomes years of regulatory roadblocks, wins FDA approval
Boston Scientific finally won FDA approval for its stroke-fighting Watchman device after setbacks and rejections in 2010 and 2014. The...
more>>
Case Reports
 
GIANT CARDIAC HYDATID CYST WITH RARE ADHESIONS We present a 29-year-old woman admitted... QUADRICUSPID PULMONARY VALVE IN AN ADULT PATIENT We describe a case of quadricuspid pulmonary...
 
more>>
Hot Articles
Regular intake of alcohol linked to elevated BP in premenopausal women Alcohol consumption is associated with elevated BP in healthy premenopausal women to a similar degree as reported in previous studies with men, according to neThe researchers wrote...
Proton pump inhibitors may increase MI risk Adults in the U.S. exposed to proton pump inhibitors were at increased risk for developing MI in a recent data-mining study. The researchers evaluated data collected from more than 16...
Analysis From the RE-LY Trial: Changes in Renal Function in Patients With AF Patients with atrial fibrillation (AF) receiving oral anticoagulation exhibited a decline in renal function that was greater in those taking warfarin versus dabigatran, and it was...
Opioid use associated with increased prevalence of AF Opioid use was independently associated with increased prevalence of atrial fibrillation in a new analysis from the Reasons for Geographic and Racial Differences in Stroke, or REGARDS,...
PCSK9 inhibitors reduce mortality, MI According to a systematic review and meta-analysis of trials of PCSK9 inhibitors, the novel cholesterol-lowering agents are associated with reductions in mortality and MI. Cainzos-Achirica M,...
Smoking cessation at an older age reduces risks for stroke, death Adults aged 60 years or older who stopped smoking even later in life were at reduced risk for cardiovascular events and death, according to study results. BMJ. 2015;doi:10.1136/bmj.h1551. ...
Apixaban does not increase bleeding in patients with renal insufficiencies Compared with conventional anticoagulants, use of apixaban resulted in a lower bleeding risk in patients with mild or moderate-to-severe renal impairment, according to results of a...
Patient genotyping identifies increased bleeding risk with warfarin treatment Patients with a genetic sensitivity to warfarin and increased rates of bleeding in the first several months of treatment stand to benefit from use of an alternate anticoagulant drug, according to...
Amiodarone associated with acute pancreatitis in patients with AF Acute pancreatitis could be an adverse effect of amiodarone use in patients with atrial fibrillation, according to results of a nested case-control study. An association...
Ranolazine Reduces the Late Recurrences of Atrial Fibrillation. The 500+750 mg RAN doses reduced the recurrence of AF compared with placebo + the ineffective 375 mg dose. The data suggest that ranolazine may be less effective early after CV when...
Elevated circulating troponin linked to AF risk in older adults In ambulatory older adults, circulating troponin T levels appear to be significantly associated with incident atrial fibrillation, according to recent findings. Heart...
Commonly used clinical risk calculators overestimate CV events Four commonly used risk scores, including the newer American College of Cardiology/American Heart Association atherosclerotic CVD risk score, may overestimate CV events by up to 67% in women...
more>>
HCS NEWS
Free Registration to EUROCVP 2015 Congress in Rome
April 28 2015
The WG on Pharmacology and Drug Therapy is happy to give to the Young Association of EACVI 50 free registrations to the Course All About Clinical...
36th International Congress of Cardiology- Abstract Submission
March 30 2015
We would like to inform you that the 36th International Cardiology Congress is due to take place on October 29-31 2015, in Thessaloniki, Greece...
ESC CONGRESS 2015
March 23 2015
29 Aug 2015 - 02 Sep 2015 , London - United Kingdom Please browse through the...
World Heart Federation Members Webinar: CVD and the Development Agenda: Advocacy Toolkit- Wednesday 18 March, 16:00 Central European Time
March 17 2015
New Webinar frome the Word Heart Federation. Click here for more details.
ESC Congress News 2014
September 11 2014
Please find below the most important ESC Congress News 2014 SATURDAY 30 AUGUST SUNDAY 31 AUGUST MONDAY 1 SEPTEMBER TUESDAY 2 SEPTEMBER WEDNESDAY...
INAUGUAL SESSION ESC Congress 2014
August 19 2014
INAUGUAL SESSION ESC Congress 2014 Saturday 30 August Barcelona - Central Village 16:30-18:00 We invite all delegates to join this...
Catalogue with the most influential Greek scientists‏
August 7 2014
The list with the most influential Greek scientists is part of a study conducted by Prof. John Ioannidis (University of Ioannina &...
RAFFTING PUBLICATION IN THE INTERNATIONAL JOURNAL OF CARDIOLOGY
August 1 2014
Results from the official Registry of the Hellenic Society of Cardiology RAFTING (Registry of Atrial Fibrillation To Investigate New Guidelines)...
35th INTERNATIONAL CARDIOLOGICAL CONGRESS- ABSTRACT SUBMISSION
May 26 2014
We would like to inform you that the deadline for abstract submission is extended until 30/5/2014.
HEART FAILURE 2014- Athens 17-20 May, OPENING CEREMONY
May 13 2014
35th INTERNATIONAL CARDIOLOGICAL CONGRESS- ABSTRACT SUBMISSION
May 7 2014
We would like to inform you that the deadline for abstract submission is extended until 18/5/2014.
HEART FAILURE 2014- Athens 17-20 May, Free Registration for Greek Residents
April 24 2014
Cardiology Update 2015 21st International Postgraduate Course on Cardiovascular Disease
April 8 2014
EUROPEAN HEART JOURNAL CARDIOVASCULAR IMAGING
March 25 2014
Volume: 15 / Number: 4 / Publication Date: March 2014 / Owner: European Society of Cardiology
U.E.M.S. Cardiology Section
February 13 2014
Dear delegates to UEMS Cardiology Section, this is to notify you that the European Society of Cardiology (ESC) and UEMS Cardiology Section (CS),...
EUROPEAN HEART JOURNAL CARDIOVASCULAR IMAGING
January 28 2014
Volume: 15 / Number: 2 / Publication Date: February 2014 / Publisher: European Society of Cardiology
REGISTRATION AT HEART FAILURE 2014 IN ATHENS
January 21 2014
Τhe HFA Board has designed special prices for the Greek participants: -Free for Local Medical Students -200€ for local...
INNOVATION IN EDUCATION AT WORK
January 20 2014
For more information please click here.
SURGERY IN SEVERE MITRAL REGURGITATION: FOCUS ON PATIENTS WITH NO SYMPTOMS OR COMPLICATIONS
An article from the e-journal of the ESC Council for Cardiology Practice Mitral valve repair is often recommended in severe mitral regurgitation...
HEART FAILURE 2014 ABSTRACT SUBMISSION
Abstract submission deadline: 21 January 2014. For more information please click here.
more >>
cardiomap

 
als-video
Επίδειξη Σεμιναρίου ALS (Advanced Life Support- Εξειδικευμένη Υποστήριξη Ζωής) σε σεμινάριο στην Ελληνική Καρδιολογική Εταιρεία, σε συνεργασία με το ERC (European Resuscitation Council)
Πρόεδρος ΕΚΕ Ι. Καλλικάζαρος
Υπεύθυνος ALS Γ. Λάτσιος
 
 
6 Potamianou 11528 Athens
Phone: +30 210 722 1633, 210 725 8003-8
Fax: +30 210 722 6139
 
facebook    twitter
 
    Sponsors
Powered: By Inspirit Graphics Studio